Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

In-Vitro Colorectal Cancer Screening Tests Market : Non-Invasive Colorectal Cancer Screening To Show Appreciable Rise

Transparency Market Research
Posted on: 14 Oct 16
In-Vitro Colorectal Cancer Screening Tests Market : Non-Invasive Colorectal Cancer Screening To Show Appreciable Rise

The top three players in the global in-vitro colorectal cancer screening tests market are Sysmex Corporation, Quest Diagnostics, Inc., and Beckman Coulter, Inc. The collective share of these players, in terms of revenue, stood at 68.3% in 2014. Transparency Market Research observes that only a few players dominate the global market, as sustainability in the market demands high investment in research and development. This factor has dissuaded new entrants from entering the market to a large extent. “Product innovation is expected to be the key growth strategy of the players in the global market,” states the lead author of this research report.

Colorectal cancer, the third most common type of cancer worldwide, affected 1.4 mn people in 2012, says the World Cancer Research Fund International. In the next nine years (by 2035), the world will have nearly 2.4 mn colorectal cancer patients. Korea was the country with the highest rate of colorectal cancer, followed by Slovakia, Hungary, Denmark, and the Netherlands in the top five. These figures underline the rapid spread of the disease and the need to diagnose it at an early stage so patients can go back to leading a normal life as soon as possible. That has directly impacted the In-vitro colorectal cancer screening tests market, with demand for such tests having surged over the past few years.

Request Sample pages of premium Research Report: http://bit.ly/2cJ3bdp

Europe to Progress at a Noteworthy CAGR of 8.3% 2015-2023

According to the research report, the global in-vitro colorectal cancer screening tests market is expected to be worth US$980.6 mn by the end of 2023 from US$602.3 mn by the end of 2016. The global market is anticipated to expand at a CAGR of 7.5% between 2015 and 2023. Europe is expected to be a lucrative market for the in-vitro colorectal cancer screening testing as the region is witnessing a high incidence of colorectal cancer amongst the geriatrics. The regional market is expected to progress at a CAGR of 8.3% during the forecast period. The blood biomarkers tests are expected to register a significant CAGR of 9.9% due to the development of technologies associated with genomics and proteomics.

High Incidence of Colorectal Cancer amongst Geriatrics Encourages Uptake of Screening Tests

The primary factor driving the growth of the global in-vitro colorectal cancer screening test market is the increasing preference for the non-invasive diagnostics. The huge pool of geriatrics, who are also fueling the growth of this market, are opting for the non-invasive measure as they reduce recovery time and offer ease of operation to the medical professional. These methods also eliminate the hassle of dietary restrictions and are also known to be exceptionally effective.

The market is also being favored by growing number of people with a history of inflammatory bowel disease such as Crohn’s disease, which has a tendency to result in colorectal cancer. Furthermore, rising number patients suffering from infections to the gastrointestinal system, respiratory tract, and ulcerative colitis has also created a significant surge in the number of in-vitro colorectal cancer screening tests in recent past. The growing number of diabetics are also projected to contribute toward the rise of the global market as they remain susceptible to such diseases.

Substantial advancements in technology, which has rendered a positive effect on the life expectancy of patients, have played a vital role in the growth of this market. The growing awareness about the disease and increased spending by the governments to spread awareness about it has also made a significant contribution to the global market.

View exclusive Global strategic Business report :  http://www.transparencymarketresearch.com/in-vitro-colorectal-cancer-screening-tests-market.html

Tough Compliance Norms Deter Global Market

The rigmarole of obtaining approvals for in-vitro colorectal cancer screening tests has been the Herculean task for several companies operating in the global market. The companies are expected to find it even more difficult as the regulatory norms are getting even tougher to comply with. The U.S. FDA and EMA have made their protocol severely strict in recent years for both existing players as well as new entrants. Thus, this is expected to restrain the global market to a significant extent in the near future. The poor reimbursement schemes, especially in the developing countries are also hampering the overall market.

 

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

 

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website:  http://www.transparencymarketresearch.com/

 

For more information:
www.transparencymarketresearch.com

Editor's Details

Ranu Kurmi
Transparency Market Research
www.transparencymarketresearch.com
+1-518-618-1030
ranu.k@transparencymarketresearch.com

Last updated on: 14/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.